The Online Investor

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Thu., Feb. 22, 9:23 AM

Slide #1. Aimmune Therapeutics, Inc. Secondary Offering

Company: Aimmune Therapeutics, Inc. (NASDAQ:AIMT)
Date announced: 2/20/2018
Secondary Offering Details: Aimmune Therapeutics, Inc. (NASDAQ:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that it has commenced an underwritten public offering of up to $150,000,000 of shares of its common stock. All of the shares to be sold in the offering will be offered by Aimmune. In addition, Aimmune expects to grant the underwriters of the offering a 30-day option to purchase up to an additional $22,500,000 of shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Aimmune Therapeutics is a clinical-stage biopharmaceutical company focused on a therapeutic approach that includes the development of proprietary product candidates for the treatment of peanut and other food allergies. Co.'s therapeutic approach, Characterized Oral Desensitization Immunotherapy (CODIT™), is designed to desensitize patients to food allergens and thereby reduce the risk of having an allergic reaction upon accidental exposure, or reduce symptom severity should an allergic reaction occur. Co. is developing its CODIT product candidate, AR101, for the treatment of peanut allergy.

AIMT SEC Filing Email Alerts Service

Open the AIMT Page at The Online Investor »

Company Name: 
Aimmune Therapeutics Inc
Website: 
www.aimmune.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding AIMT: 
16
Total Market Value Held by ETFs: 
$98.70M
Total Market Capitalization: 
$1.80B
% of Market Cap. Held by ETFs: 
5.48%
 

Open the AIMT Page at The Online Investor (in a new window) »

List of Secondary Stock Offerings in this Slideshow:

2/6/2018:
Company: The Simply Good Foods Company (SMPL)
Shares Offered: 8,843,174
More: offering details »

2/7/2018:
Company: Viveve Medical, Inc. (VIVE)
Shares Offered: 10,000,000
More: offering details »

2/7/2018:
Company: MediciNova, Inc. (MNOV)
Shares Offered: 4,419,890
More: offering details »

2/7/2018:
Company: Sage Therapeutics (SAGE)
Shares Offered: 3,506,098
More: offering details »

2/7/2018:
Company: Adverum Biotechnologies, Inc. (ADVM)
Shares Offered: 8,888,900
More: offering details »

2/7/2018:
Company: Everspin Technologies, Inc. (MRAM)
Shares Offered: 3,600,000
More: offering details »

2/7/2018:
Company: Oaktree Capital Group, LLC (OAK)
Shares Offered: 5,000,000
More: offering details »

2/7/2018:
Company: Gemphire Therapeutics Inc. (GEMP)
Shares Offered: 3,142,858
More: offering details »

2/7/2018:
Company: Cadence Bancorporation (CADE)
Shares Offered: 8,000,000
More: offering details »

2/8/2018:
Company: Chembio Diagnostics, Inc. (CEMI)
Shares Offered: 1,783,760
More: offering details »

2/12/2018:
Company: Daseke, Inc. (DSKE)
Shares Offered: 7,500,000
More: offering details »

2/12/2018:
Company: Pacific Biosciences of California, Inc. (PACB)
Shares Offered: 12,500,000
More: offering details »

2/12/2018:
Company: Catalyst Biosciences, Inc. (CBIO)
Shares Offered: 2,941,176
More: offering details »

2/13/2018:
Company: Pieris Pharmaceuticals, Inc. (PIRS)
Shares Offered: 5,500,000
More: offering details »

2/13/2018:
Company: Navios Maritime Partners L.P. (NMM)
Shares Offered: 18,400,000
More: offering details »

2/13/2018:
Company: Black Knight, Inc. (BKI)
Shares Offered: 8,000,000
More: offering details »

2/13/2018:
Company: Ra Pharmaceuticals, Inc. (RARX)
Shares Offered: 8,400,000
More: offering details »

2/14/2018:
Company: Avid Bioservices, Inc. (CDMO)
Shares Offered: 9,000,000
More: offering details »

2/14/2018:
Company: Amicus Therapeutics (FOLD)
Shares Offered: 19,354,839
More: offering details »

2/14/2018:
Company: Atkore International Group Inc. (ATKR)
Shares Offered: 6,000,000
More: offering details »

2/15/2018:
Company: Instructure, Inc. (INST)
Shares Offered: 2,500,000
More: offering details »

2/15/2018:
Company: Nano Dimension Ltd. (NNDM)
More: offering details »

2/20/2018:
Company: Ascendis Pharma A/S (ASND)
More: offering details »

2/20/2018:
Company: Dova Pharmaceuticals, Inc. (DOVA)
Shares Offered: 2,500,000
More: offering details »

2/20/2018:
Company: Aimmune Therapeutics, Inc. (AIMT)
More: offering details »

Quotes delayed 20 minutes



Strong Buy (3.87 out of 4)
81st percentile
(ranked higher than approx. 81% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2018, All Rights Reserved Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.